This post is an authorized copy of a press release and was not written by LegalReader.


Robins Kaplan Trial Win for Amneal Pharmaceuticals Over Generic Sensipar

On July 26, 2018, Robins Kaplan LLP® secured a ruling of non-infringement of a proposed ANDA product in a Hatch-Waxman trial over the blockbuster kidney disease drug Sensipar®. The ruling, following a four-day trial in Delaware federal court, is a victory for Robins Kaplan’s client, Amneal Pharmaceuticals LLC.


Big Business has a Friend in Judge Brett Kavanaugh

Public Citizen issued an announcement today regarding U.S. Supreme Court nominee Judge Brett Kavanaugh. What follows details the organization’s look into Judge Kavanaugh’s judicial record and the impact it could have on U.S. consumers and the environment.





Lex Machina Releases New Trade Secret Litigation Report

Our friends at Lex Machina, a LexisNexis company and creator of the award-winning Legal Analytics® platform, recently announced the release of the company’s first-ever Trade Secret Litigation Report, which represents the most comprehensive and accurate dataset available for analyzing trade secret misappropriation cases. The new report reveals trends and insights from litigation that encompasses more